BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2050162)

  • 1. Localization and management of occult breast lesions.
    Zola P; Volpe T; Luparia E; Rumore A; Katsaros D; Sismondi P
    Eur J Gynaecol Oncol; 1991; 12(1):63-8. PubMed ID: 2050162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric DNA analysis of excised breast lesions: use of fresh tissue needle aspirates obtained under guidance with mammography of the specimen.
    Stomper PC; Stewart CC; Penetrante RB; Nava ME; Tsangaris TN
    Radiology; 1992 Nov; 185(2):415-22. PubMed ID: 1329141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced CT evaluation of clinically and mammographically occult multiple breast tumors in women with unilateral early breast cancer.
    Taira N; Ohsumi S; Takabatake D; Hara F; Takashima S; Aogi K; Takashima S; Inoue T; Sugata S; Nishimura R
    Jpn J Clin Oncol; 2008 Jun; 38(6):419-25. PubMed ID: 18502779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The attitude before subclinical breast lesions on mammography].
    Blidaru A; Sebeni M; Bordea C; Viişoreanu C; Bălănescu I
    Chirurgia (Bucur); 2000; 95(2):109-17. PubMed ID: 14768315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Needle-localized biopsy of occult breast lesions: an update.
    Snell MJ; Ostrow LB; DuBois JJ; Boyle LM; Calfee LW
    Mil Med; 1992 Feb; 157(2):61-4. PubMed ID: 1318524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic 14 gauge core-biopsy of the breast: results from 101 patients.
    Frayne J; Sterrett GF; Harvey J; Goodwin P; Townsend J; Ingram D; Parsons RW
    Aust N Z J Surg; 1996 Sep; 66(9):585-91. PubMed ID: 8859155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of nonpalpable mammographic abnormalities using guidewire localization].
    Ben Aharon U; Lifscitz O; Strano SD; Mavor E; Barzilai N
    Harefuah; 1995 Feb; 128(4):205-7, 264. PubMed ID: 7744325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ breast cancer: a multidisciplinary approach.
    Robert NJ; Wazer DE; Smith TJ; Homer MJ; Safaii H; Marchant DJ
    Hosp Pract (Off Ed); 1989 Apr; 24(4):169-76, 179-85. PubMed ID: 2538488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic localization and biopsy: the experience of a gynecologic oncology group.
    Stock RJ; Kunschner A; Mazer J; Murphy A
    Gynecol Oncol; 1989 May; 33(2):172-6. PubMed ID: 2703176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wire-directed localization biopsy of the breast: an audit of results and analysis of factors influencing therapeutic value in the treatment of breast cancer.
    Chadwick DR; Shorthouse AJ
    Eur J Surg Oncol; 1997 Apr; 23(2):128-33. PubMed ID: 9158186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast.
    Obdeijn IM; Brouwers-Kuyper EM; Tilanus-Linthorst MM; Wiggers T; Oudkerk M
    AJR Am J Roentgenol; 2000 Apr; 174(4):1079-84. PubMed ID: 10749254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioguided occult lesion localization (ROLL) for treatment and diagnosis of malignant and premalignant breast lesions combined with sentinel node biopsy: a prospective clinical trial with 100 patients.
    Sarlos D; Frey LD; Haueisen H; Landmann G; Kots LA; Schaer G
    Eur J Surg Oncol; 2009 Apr; 35(4):403-8. PubMed ID: 18692358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically occult breast carcinoma: diagnostic approaches and role of axillary node dissection.
    Meterissian S; Fornage BD; Singletary SE
    Ann Surg Oncol; 1995 Jul; 2(4):314-8. PubMed ID: 7552620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography in symptomatic breast disease.
    Locker AP; Manhire AR; Stickland V; Caseldine J; Blamey RW
    Lancet; 1989 Apr; 1(8643):887-9. PubMed ID: 2564959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoma in situ of the breast: 10 cases].
    Salvat J; Knopf JF; Vincent-Genod A; Fellahi L
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(8):1051-8. PubMed ID: 2853184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult breast lesions and aspiration biopsy: a new challenge.
    Masood S
    Diagn Cytopathol; 1993 Dec; 9(6):613-4. PubMed ID: 8143532
    [No Abstract]   [Full Text] [Related]  

  • 17. Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequential.
    Schwartz GF; Carter DL; Conant EF; Gannon FH; Finkel GC; Feig SA
    Cancer; 1994 Mar; 73(6):1660-5. PubMed ID: 8156493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method of tumor detection influences disease-free survival of women with breast carcinoma.
    Senie RT; Lesser M; Kinne DW; Rosen PP
    Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specimen radiographs assist in identifying and assessing resection margins of occult breast carcinomas.
    Young ES; Hogg DE; Krontiras H; Bernreuter W; Urist M; Bland KI; Chhieng DC
    Breast J; 2009; 15(5):521-3. PubMed ID: 19624413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of localized breast cancer by prospective mammographic screening criteria.
    Knaus JV; Dolan JR; Isaacs JH
    Am J Obstet Gynecol; 1988 Jan; 158(1):147-9. PubMed ID: 2827485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.